View drug registration information details.
Items | Registration information |
ID | 1568 |
No | 1568 |
Brand Name | ATORZET 10/20 |
Ingredients | ATORVASTATIN CALCIUM EQ.TO ATORVASTATIN 20 MG, EZETIMIBE 10 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | AS SUBSTITUTION THERAPY FOR TREATMENT OF ADULTS WITH PRIMARY (HETEROZYGOUS AND HOMOZYGOUS FAMILIAL AND NON-FAMILIAL) HYPERCHOLESTEROLAEMIA OR MIXED HYPERLIPIDAEMIA ALREADY CONTROLLED WITH ATORVASTATIN AND EZETIMIBE GIVEN CONCURRENTLY AT THE SAME DOSE LEVEL |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | ORANGE COLORED, ROUND SHAPED BICONVEX, FILM COATED TABLET, PLAIN ON BOTH SIDE |
Note | |
License Owner | LAO NIYOM PHARMA SOLE CO.,LTD |
Manufacturer | MEDIWIN PHARMACEUTICALS |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 08 I 5595/23 |
FDD Registration Date | 05-SEP-2023 |
Expiry Date | 04-SEP-2026 |
Back to drug list
|